Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Effects of dual-task balance training on postural performance in patients with Multiple Sclerosis: a double-blind, randomized controlled pilot trial.

Authors:
Saeideh Monjezi Hossein Negahban Shirin Tajali Nava Yadollahpour Nastaran Majdinasab

Clin Rehabil 2017 Feb 10;31(2):234-241. Epub 2016 Jul 10.

4 Neurologist, Department of Neurology, Musculoskeletal Rehabilitation Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Objective: To investigate the effects of dual-task balance training on postural performance in patients with multiple sclerosis as compared with single-task balance training.

Design: Double-blind, pretest-posttest, randomized controlled pilot trial.

Setting: Local Multiple Sclerosis Society.

Subjects: A total of 47 patients were randomly assigned to two equal groups labeled as single-task training and dual-task training groups.

Interventions: All patients received supervised balance training sessions, 3 times per week for 4 weeks. The patients in the single-task group performed balance activities, alone. However, patients in dual-task group practiced balance activities while simultaneously performing cognitive tasks.

Main Measures: The 10-Meter Walk Test and Timed Up-and-Go under single-task and dual-task conditions, in addition to Activities-specific Balance Confidence, Berg Balance Scale, and Functional Gait Assessment were assessed pre-, and post intervention and also 6-weeks after the end of intervention.

Results: Only 38 patients completed the treatment plan. There was no difference in the amount of improvement seen between the two study groups. In both groups there was a significant effect of time for dual-10 Meter Walk Test (F=11.33, p=0.002) and dual-Timed Up-and-Go (F=14.27, p=0.001) but not for their single-tasks. Moreover, there was a significant effect of time for Activities-specific Balance Confidence, Berg Balance Scale, and Functional Gait Assessment ( P<0.01).

Conclusions: This pilot study did not show more benefits from undertaking dual-task training than single-task training. A power analysis showed 71 patients per group would be needed to determine whether there was a clinically relevant difference for dual-task gait speed between the groups.

Download full-text PDF

Source
http://dx.doi.org/10.1177/0269215516639735DOI Listing
February 2017

Publication Analysis

Top Keywords

multiple sclerosis
12
balance training
12
balance
10
gait assessment
8
randomized controlled
8
balance activities
8
functional gait
8
controlled pilot
8
berg balance
8
activities-specific balance
8
balance confidence
8
confidence berg
8
balance scale
8
scale functional
8
walk test
8
training postural
8
dual-task balance
8
effects dual-task
8
postural performance
8
performance patients
8

Altmetric Statistics


Show full details
1 Total Shares
1 Tweets
1 Citations

Similar Publications

Oral dimethyl fumarate induces changes within the peripheral neutrophil compartment of psoriasis patients that are linked with skin improvement.

Authors:
P J Morrison I Suhrkamp S Gerdes U Mrowietz

Br J Dermatol 2021 Mar 3. Epub 2021 Mar 3.

Psoriasis Center, Department of Dermatology, University Medical Center Schleswig-Holstein, Campus Kiel, 24105, Kiel, Germany.

Background: Dimethyl fumarate (DMF) is a treatment for moderate-to-severe psoriasis and multiple sclerosis. DMF therapy typically improves skin inflammation within the first 3 months of treatment. DMF is a prodrug that generates the hydroxycarboxylic acid receptor 2 (HCA2) agonist, monomethyl fumarate (MMF). Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Class II HLA (DRB1, & DQB1) alleles and IL7R (rs6897932) variants and the risk for Multiple Sclerosis in Kerala, India.

Authors:
Navia Vinoy Neethu Sheeja Suresh Kumar Lalitha Biswas

Mult Scler Relat Disord 2021 Feb 20;50:102848. Epub 2021 Feb 20.

Centre for Nanosciences and Molecular Medicine, Amrita Vishwa Vidyapeetham, Ponekkara, Kochi, Kerala 682041, India. Electronic address:

Background: Different human leukocyte antigen (HLA) variants are known to modulate the risk of multiple sclerosis. The main objective of this study was to identify HLA-DRB1 and HLA-DQB1 alleles and Non -HLA gene IL7R (rs6897932) variants associated with MS.

Methods: Patients attending the MS clinic, diagnosed with Multiple Sclerosis as per Mc Donald diagnostic criteria were the subjects in the study. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Altered in vivo brain GABA and glutamate levels are associated with multiple sclerosis central fatigue.

Authors:
Jameen Arm Georg Oeltzschner Oun Al-Iedani Rod Lea Jeannette Lechner-Scott Saadallah Ramadan

Eur J Radiol 2021 Feb 24;137:109610. Epub 2021 Feb 24.

School of Health Sciences, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, 2308, Australia; Hunter Medical Research Institute, 1 Kookaburra Circuit, New Lambton, NSW, 2305, Australia. Electronic address:

Purpose: Fatigue is a common symptom in patients with multiple sclerosis (MS) with unknown pathophysiology. Dysfunction of the GABAergic/glutamatergic pathways involving inhibitory and excitatory neurotransmitters such as  γ-aminobutyric acid (GABA) and glutamine + glutamate pool (Glx) have been implicated in several neurological disorders. This study is aimed to evaluate the potential role of GABA and Glx in the origin of central fatigue in relapse remitting MS (RRMS) patients. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Correction for: Signatures of cell stress and altered bioenergetics in skin fibroblasts from patients with multiple sclerosis.

Authors:
Jordan M Wilkins Oleksandr Gakh Parijat Kabiraj Christina B McCarthy W Oliver Tobin Charles L Howe Claudia F Lucchinetti

Aging (Albany NY) 2021 03 3. Epub 2021 Mar 3.

Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA.

View Article and Full-Text PDF
March 2021
Similar Publications

Effects on Motor Control of Personalized Neuromodulation Against Multiple Sclerosis Fatigue.

Authors:
Matteo Padalino Carla Scardino Giancarlo Zito Andrea Cancelli Carlo Cottone Massimo Bertoli Eugenia Gianni Teresa L'Abbate Elisabetta Trombetta Camillo Porcaro Fabiano Bini Franco Marinozzi Maria Maddalena Filippi Franca Tecchio

Brain Topogr 2021 Mar 3. Epub 2021 Mar 3.

LET'S-ISTC-CNR, via Palestro 32, 00185, Rome, Italy.

Fatigue is a hidden symptom of Multiple Sclerosis (MS) disease that nevertheless impacts severely on patients' everyday life. Evidence indicates the involvement of the sensorimotor network and its inter-nodes communication at the basis of this symptom. Two randomized controlled trials (RCTs) showed that the personalized neuromodulation called Fatigue Relief in Multiple Sclerosis (FaReMuS) efficaciously fights multiple sclerosis (MS) fatigue. Read More

View Article and Full-Text PDF
March 2021
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap